Hybrid core-shell particles for mRNA systemic delivery - CRCL-OncoPharmacologie Access content directly
Journal Articles Journal of Controlled Release Year : 2023

Hybrid core-shell particles for mRNA systemic delivery

Kerstin Walzer
  • Function : Author
Ugur Sahin
  • Function : Author
Heinrich Haas
  • Function : Author


mRNA based infectious disease vaccines have opened the venue for development of novel nucleic acids-based therapeutics. For all mRNA therapeutics dedicated delivery systems are required, where different functionalities and targeting abilities need to be optimized for the respective applications. One option for advanced formulations with tailored properties are lipid-polymer hybrid nanoparticles with complex nanostructure, which allow to combine features of several already well described nucleic acid delivery systems. Here, we explored hyaluronic acid (HA) as coating of liposome-mRNA complexes (LRCs) to investigate effects of the coating on surface charge, physicochemical characteristics and biological activity. HA was electrostatically attached to positively charged complexes, forming hybrid LRCs (HLRCs). At different N/P ratios, physico-chemical characterization of the two sets of particles showed similarity in size (around 200 nm) and mRNA binding abilities, while the presence of the HA shell conferred a negative surface charge to otherwise positive complexes. High transfection efficiency of LRCs and HLRCs in vitro has been obtained in THP-1 and human monocytes derived from PBMC, an interesting target cell population for cancer and immune related pathologies. In mice, quantitative biodistribution of radiolabeled LRC and HLRC particles, coupled with bioluminescence studies to detect the protein translation sites, hinted towards both particles' accumulation in the hepatic reticuloendothelial system (RES). mRNA translated proteins though was found mainly in the spleen, a major source for immune cells, with preference for expression in macrophages. The results showed that surface modifications of liposome-mRNA complexes can be used to fine-tune nanoparticle physico-chemical characteristics. This provides a tool for assembly of stable and optimized nanoparticles, which are prerequisite for future therapeutic interventions using mRNA-based nanomedicines.
Fichier principal
Vignette du fichier
Andretto V 2023 J Contr Rel.pdf (8.23 Mo) Télécharger le fichier
Origin Publication funded by an institution

Dates and versions

hal-04082346 , version 1 (18-07-2023)



Valentina Andretto, Mathieu Repellin, Marine Pujol, Eyad Almouazen, Jacqueline Sidi-Boumedine, et al.. Hybrid core-shell particles for mRNA systemic delivery. Journal of Controlled Release, 2023, 353, pp.1037-1049. ⟨10.1016/j.jconrel.2022.11.042⟩. ⟨hal-04082346⟩
68 View
39 Download



Gmail Mastodon Facebook X LinkedIn More